{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:48:40Z","timestamp":1782200920592,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.transci.2026.104404","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:45:03Z","timestamp":1770655503000},"page":"104404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants"],"prefix":"10.1016","volume":"65","author":[{"given":"Michelle","family":"Lavoignet-Cisneros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia Joanna","family":"Alberto-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Viveros-Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Couriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Robles-Nasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Ch\u00e1vez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Daniela","family":"Salgado-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Olivares-Gazca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Jos\u00e9","family":"Ruiz-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-0653","authenticated-orcid":false,"given":"Guillermo Jos\u00e9","family":"Ruiz-Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104404_bib1","unstructured":"FACT-JACIE International Standards for hematopoietic cellular therapy. 2021."},{"issue":"10","key":"10.1016\/j.transci.2026.104404_bib2","first-page":"1232","article-title":"Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation","volume":"89","author":"Larrea","year":"2004","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/PAT.0b013e32834642ec","article-title":"Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies","volume":"43","author":"Cheah","year":"2011","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jinf.2008.01.012","article-title":"Propionibacterium acnes is a common colonizer of intravascular catheters","volume":"56","author":"Mart\u00edn-Rabad\u00e1n","year":"2008","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.transci.2026.104404_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12879-015-1306-0","article-title":"Rapid diagnosis of Propionibacterium acnes infection in patient with hyperpyrexia after hematopoietic stem cell transplantation by next-generation sequencing: a case report","volume":"16","author":"Ye","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.transci.2026.104404_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.transci.2026.104404_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41409-025-02544-y","article-title":"Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patients","volume":"60","author":"Lira-Lara","year":"2025","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000469655","article-title":"A feasibility study of the full outpatient conduction of hematopoietic transplants in persons with multiple sclerosis employing autologous non-cryopreserved peripheral blood stem cells","volume":"137","author":"Ruiz-Arg\u00fcelles","year":"2017","journal-title":"Acta Haematol"},{"key":"10.1016\/j.transci.2026.104404_bib9","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202163077","article-title":"Effectiveness of surveillance cultures for high priority multidrug-resistant bacteria in hematopoietic stem cell transplant units","volume":"63","author":"Mendes","year":"2021","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"10.1016\/j.transci.2026.104404_bib10","first-page":"67","article-title":"Utility of daily catheter-drawn blood cultures to predict catheter-related bacteremia in hematopoietic stem cell transplanted patients","volume":"26","author":"Velasco","year":"2009","journal-title":"Turk J Haematol"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.hemonc.2017.05.018","article-title":"Complications of hematopoietic stem cell transplantation","volume":"10","author":"Omrani","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.transci.2026.104404_bib12","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2147\/IDR.S463868","article-title":"Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation","volume":"17","author":"Kamel","year":"2024","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib13","first-page":"269.e1","article-title":"Bloodstream Infections and Colonization in Hematopoietic Stem Cell Transplant Recipients at a South African Center: A Retrospective Analysis","volume":"31","author":"van Leeuwen","year":"2025","journal-title":"Transpl Cell Ther"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.chest.2020.06.011","article-title":"Bloodstream Infections and Delayed Antibiotic Coverage Are Associated With Negative Hospital Outcomes in Hematopoietic Stem Cell Transplant Recipients","volume":"158","author":"Ji","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.transci.2026.104404_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hemonc.2016.09.002","article-title":"Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens","volume":"10","author":"Stoma","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.transci.2026.104404_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jhin.2021.04.006","article-title":"Prevalence and significance of bacterial contamination of autologous stem cell products","volume":"114","author":"Damonti","year":"2021","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.transci.2026.104404_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.bmt.1705731","article-title":"Microbial contamination of hematopoietic progenitor cell products: clinical outcome","volume":"40","author":"Patah","year":"2007","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"10.1016\/j.transci.2026.104404_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1705549","article-title":"Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant","volume":"39","author":"Majado","year":"2007","journal-title":"Bone Marrow Transpl"},{"issue":"11","key":"10.1016\/j.transci.2026.104404_bib19","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/trf.12150","article-title":"Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine","volume":"53","author":"Jacobs","year":"2013","journal-title":"Transfus (Paris)"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bjid.2012.06.012","article-title":"Autologous transplant: microbial contamination of hematopoietic stem cell products","volume":"16","author":"Dullius Almeida","year":"2012","journal-title":"Braz J Infect Dis"},{"issue":"11","key":"10.1016\/j.transci.2026.104404_bib21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bbmt.2006.06.011","article-title":"Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae","volume":"12","author":"Klein","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.transci.2026.104404_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bmt.1702542","article-title":"A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells\/kg be considered the minimum threshold?","volume":"26","author":"Singhal","year":"2000","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2026.104404_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clml.2019.12.018","article-title":"Adequate engraftment with lower hematopoietic stem cell dose","volume":"20","author":"Jeyaraman","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:19:18Z","timestamp":1782199158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1473050226000364"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104404","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104404"}}